Nine Chapters Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Nine Chapters Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,100	Closed	-$579K	–	300
2016 Q4	$579K	Buy	+4,100	New	+$604K	0.98%	28
2015 Q1	–	Sell	-14,600	Closed	-$1.83M	–	1129
2014 Q4	$1.83M	Buy	+14,600	New	+$1.78M	0.16%	178
2014 Q3	–	Sell	-27,300	Closed	-$3.22M	–	1165
2014 Q2	$3.22M	Sell	27,300 -20,200	-43%	-$2.38M	0.26%	95
2014 Q1	$5.71M	Buy	+47,500	New	+$5.65M	0.67%	13

Other funds holding TMO

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Nine Chapters Capital Management's TMO Position: Q1 2017 in Review

Nine Chapters Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2017, closing a stake of 4,100 shares — an estimated $579K sold.

Nine Chapters Capital Management first reported a position in TMO in Q1 2014 and held it in 4 quarters. The position peaked at $5.71M in Q1 2014. 1,135 funds tracked by Wall St. Rank hold TMO as of Q1 2017.

Nine Chapters Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2017 after selling out during the quarter.
Nine Chapters Capital Management sold 4,100 Thermo Fisher Scientific shares in Q1 2017, an estimated $579K.
Nine Chapters Capital Management first reported a position in Thermo Fisher Scientific in Q1 2014 and held it in 4 quarters.
Nine Chapters Capital Management's Thermo Fisher Scientific position peaked at $5.71M in Q1 2014.
1,135 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2017.

Based on Nine Chapters Capital Management's 13F filing for Q1 2017, filed 8 May 2017.